Literature DB >> 8413200

Pi, a pre-B-cell-specific enhancer element in the immunoglobulin heavy-chain enhancer.

T A Libermann1, D Baltimore.   

Abstract

We have identified a new immunoglobulin heavy-chain enhancer element, designated pi, between the microE2 and microE3 elements. The pi enhancer element is transcriptionally active primarily during early stages of B-cell development but becomes virtually inactive during B-cell maturation at about the stage of immunoglobulin kappa light-chain gene rearrangement. Mutational analysis suggests that the pi element is crucial for immunoglobulin heavy-chain enhancer activity at the pre-B-cell stage but is almost irrelevant for enhancer activity at the mature B-cell or plasma-cell stage. The activity of the pi enhancer element correlates with the presence of an apparently pre-B-cell-specific protein-DNA complex. The similarity of the pi site to recognition sequences for members of the ets gene family suggests that the protein(s) interacting with the pi site most likely are ets-related transcription factors.

Mesh:

Substances:

Year:  1993        PMID: 8413200      PMCID: PMC364640          DOI: 10.1128/mcb.13.10.5957-5969.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  71 in total

1.  Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element.

Authors:  S Dalton; R Treisman
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

2.  Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF.

Authors:  R A Hipskind; V N Rao; C G Mueller; E S Reddy; A Nordheim
Journal:  Nature       Date:  1991 Dec 19-26       Impact factor: 49.962

3.  PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.

Authors:  J M Pongubala; S Nagulapalli; M J Klemsz; S R McKercher; R A Maki; M L Atchison
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

Review 4.  Helix-loop-helix proteins in the regulation of immunoglobulin gene transcription.

Authors:  T Kadesch
Journal:  Immunol Today       Date:  1992-01

5.  erg, an ets-related gene, codes for sequence-specific transcriptional activators.

Authors:  E S Reddy; V N Rao
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

6.  A divergent ets-related protein, elk-1, recognizes similar c-ets-1 proto-oncogene target sequences and acts as a transcriptional activator.

Authors:  V N Rao; E S Reddy
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

7.  c-ets-1 DNA binding to the PEA3 motif is differentially inhibited by all the mutations found in v-ets.

Authors:  D Leprince; P Crepieux; D Stehelin
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

8.  The mouse IgH 3'-enhancer.

Authors:  P Dariavach; G T Williams; K Campbell; S Pettersson; M S Neuberger
Journal:  Eur J Immunol       Date:  1991-06       Impact factor: 5.532

9.  Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex.

Authors:  C C Thompson; T A Brown; S L McKnight
Journal:  Science       Date:  1991-08-16       Impact factor: 47.728

10.  The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins.

Authors:  C Wasylyk; A Gutman; R Nicholson; B Wasylyk
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

View more
  11 in total

1.  Context dependent transactivation domains activate the immunoglobulin mu heavy chain gene enhancer.

Authors:  B Erman; R Sen
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

2.  Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family.

Authors:  P Oettgen; R M Alani; M A Barcinski; L Brown; Y Akbarali; J Boltax; C Kunsch; K Munger; T A Libermann
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

3.  Combinatorial determinants of tissue-specific transcription in B cells and macrophages.

Authors:  B S Nikolajczyk; M Cortes; R Feinman; R Sen
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

4.  Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1.

Authors:  P Oettgen; Y Akbarali; J Boltax; J Best; C Kunsch; T A Libermann
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

5.  Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.

Authors:  S M Maira; J M Wurtz; B Wasylyk
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

6.  Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator.

Authors:  Z Wang; A Goldstein; R T Zong; D Lin; E J Neufeld; R H Scheuermann; P W Tucker
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

7.  The V(D)J recombinational and transcriptional activities of the immunoglobulin heavy-chain intronic enhancer can be mediated through distinct protein-binding sites in a transgenic substrate.

Authors:  C Fernex; M Capone; P Ferrier
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

8.  Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells.

Authors:  H M Chen; L M Boxer
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

9.  Pax5 (BSAP) regulates the murine immunoglobulin 3' alpha enhancer by suppressing binding of NF-alpha P, a protein that controls heavy chain transcription.

Authors:  M F Neurath; E E Max; W Strober
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

10.  ERP, a new member of the ets transcription factor/oncoprotein family: cloning, characterization, and differential expression during B-lymphocyte development.

Authors:  M Lopez; P Oettgen; Y Akbarali; U Dendorfer; T A Libermann
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.